Nvidia Fuels AI Drug Discovery with $50M Investment in Recursio

In this thrilling episode, we uncover Nvidia's significant injection of $50 million into Recursion, the AI-driven drug discovery firm. Explore the profound impact of this strategic investment as it propels the frontiers of pharmaceutical research and revolutionizes the healthcare sector. Join us for an in-depth look at the dynamic synergy between technology and drug discovery in this captivating discussion! Get on the AI Box Waitlist: https://AIBox.ai/Join our ChatGPT Community: ⁠https://www.facebook.com/groups/739308654562189/⁠Follow me on Twitter: ⁠https://twitter.com/jaeden_ai⁠ See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.